Results 31 to 40 of about 209,923 (292)

Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy

open access: yesWorld Journal of Gastrointestinal Oncology, 2021
BACKGROUND A decline in serum carbohydrate antigen 19-9 (CA19-9) levels during systemic chemotherapy is considered as a prognostic marker for patients with advanced pancreatic cancer. Neutrophil-to-lymphocyte ratio (NLR) has been extensively studied as a
K. Shin   +5 more
semanticscholar   +1 more source

Reactivity of CA19-9 and CA125 in Histological Subtypes of Epithelial Ovarian Tumors and Ovarian Endometriosis [PDF]

open access: yes, 2015
Previous reports have shown that some ovarian endometrioid adenocarcinomas and ovarian clear cell adenocarcinomas derive from ovarian endometriosis (OE), and that endocervical-like mucinous borderline ovarian tumors are associated with OE.
Hasegawa, Masaaki   +8 more
core   +1 more source

Relationship between serum calcium and CA 19-9 levels in colorectal cancer [PDF]

open access: yes, 2004
AIM: To examine the calcium metabolism of colorectal cancer (CRC) in patients with colorectal cancer and control patients. METHODS: Seventy newly diagnosed CRC patients were included.
Fuszek, Péter   +8 more
core   +1 more source

Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholagnitis [PDF]

open access: yes, 2018
The non-invasive differentiation of malignant and benign biliary disease is a clinical challenge. Carbohydrate antigen 19-9 (CA19-9), leucine-rich α2-glycoprotein (LRG1), interleukin 6 (IL6), pyruvate kinase M2 (PKM2), cytokeratin 19 fragment (CYFRA21.1)
Blyuss, O   +9 more
core   +2 more sources

Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer

open access: yesBJS Open, 2021
Background Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 have been proposed as useful preoperative biomarkers of extrahepatic bile duct cancer (EBDC).
H. Kim   +8 more
semanticscholar   +1 more source

Autoimmune pancreatitis associated with a pancreatic pseudocyst treated by distal pancreatectomy with splenectomy: case report [PDF]

open access: yes, 2014
Autoimmune pancreatitis is a unique type of chronic pancreatitis, which is rarely associated with pseudocyst. A 48-year-old lady was admitted to our department with a rapidly growing cystic mass in the pancreatic tail with an elevated concentration of ...
Shu-Sen Zheng   +3 more
core   +1 more source

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer [PDF]

open access: yes, 2013
AIM: To investigate activity, toxicity, and prognostic factors for survival of erlotinib and fixed dose-rate gemcitabine (FDR-Gem) in advanced pancreatic cancer.
Bria, E.   +9 more
core   +1 more source

Lanthanide-Doped Upconversion-Linked Immunosorbent Assay for the Sensitive Detection of Carbohydrate Antigen 19-9

open access: yesFrontiers in Chemistry, 2021
Lanthanide-doped upconversion nanoparticles (UCNPs) have attracted considerable attention in detection of biological analytes and bioimaging owing to their superior optical properties, including high photochemical stability, sharp emission bandwidth ...
Chaohui Zhou   +3 more
semanticscholar   +1 more source

Combined Hepatocellular-Cholangiocarcinoma (cHCC-CCA): A Rare Case of Biphenotypic Primary Liver Carcinoma in a Post-Hemicolectomy Patient [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Combined Hepatocellular-Cholangiocarcinoma (cHCC-CCA) is a rare primary liver malignancy characterised by the presence of both hepatocytic and biliary epithelial differentiation within the same tumour and is associated with a poorer prognosis compared to
Devika Venugopal, Veena Raja
doaj   +1 more source

Glycotope structures and intramolecular affinity factors of plant lectins for Tn/T antigens [PDF]

open access: yes, 2011
B
A Babino   +42 more
core   +3 more sources

Home - About - Disclaimer - Privacy